Which item is part of the management phase in substance use treatment?

Which item is part of the management phase in substance use treatment?

• A. Establishing and maintaining a therapeutic alliance
• B. Withholding information from the client
• C. Focusing solely on pharmacotherapy
• D. Isolating the client from the support system

Answer: (A)

Building and maintaining a therapeutic alliance is essential in the management phase of substance use treatment. This stage centers on sustaining engagement, fostering honest communication, and coordinating ongoing care as clients work through recovery tasks. A strong alliance helps clients feel understood, respected, and actively involved in decisions about their plan, which boosts motivation, adherence to interventions, and openness to psychosocial therapies, coping skills, and relapse-prevention strategies. It also provides a foundation for monitoring progress, addressing barriers, adjusting approaches, and coordinating with medical, mental health, and social support resources. The other options conflicted with this phase for good reasons. Withholding information from the client undermines informed consent and trust, which are crucial for effective management. Focusing solely on pharmacotherapy neglects the broader, psychosocial components that sustain long-term recovery. Isolating the client from their support system removes key social resources and accountability that support ongoing engagement in treatment.

Building and maintaining a therapeutic alliance is essential in the management phase of substance use treatment. This stage centers on sustaining engagement, fostering honest communication, and coordinating ongoing care as clients work through recovery tasks. A strong alliance helps clients feel understood, respected, and actively involved in decisions about their plan, which boosts motivation, adherence to interventions, and openness to psychosocial therapies, coping skills, and relapse-prevention strategies. It also provides a foundation for monitoring progress, addressing barriers, adjusting approaches, and coordinating with medical, mental health, and social support resources.

The other options conflicted with this phase for good reasons. Withholding information from the client undermines informed consent and trust, which are crucial for effective management. Focusing solely on pharmacotherapy neglects the broader, psychosocial components that sustain long-term recovery. Isolating the client from their support system removes key social resources and accountability that support ongoing engagement in treatment.